Scholarly Index
Taofeek K. Owonikoko
University of Maryland, Baltimore; 63,129 total citations; 527 total publications; best world rank #30
University of Maryland, Baltimore
63,129Total citations
527Total publications
88H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lung Cancer Research Studies | Lifetime | 70 | US 38 | 99.63 |
| Lung Cancer Treatments and Mutations | Lifetime | 192 | US 112 | 99.46 |
| Cancer therapeutics and mechanisms | Lifetime | 124 | US 75 | 99.18 |
| Neuroendocrine Tumor Research Advances | Lifetime | 181 | US 84 | 99.21 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 681 | US 340 | 98.52 |
| Peptidase Inhibition and Analysis | Lifetime | 601 | US 275 | 97.97 |
| Cancer Genomics and Diagnostics | Lifetime | 834 | US 444 | 98.51 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 258 | US 155 | 97.81 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 846 | US 376 | 97.94 |
| PARP inhibition in cancer therapy | Lifetime | 491 | US 230 | 94.68 |
| Cancer therapeutics and mechanisms | 2021-2025 | 30 | US 12 | 97.47 |
| Lung Cancer Research Studies | 2021-2025 | 97 | US 39 | 98.57 |
| Peptidase Inhibition and Analysis | 2021-2025 | 86 | US 25 | 97.75 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 100 | US 31 | 97.12 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 731 | US 230 | 95.55 |
| Cell death mechanisms and regulation | 2021-2025 | 231 | US 42 | 71.79 |